# A Study of NE3107 in Early Parkinson's

> **NCT06757010** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **BioVie Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Parkinsons Disease (PD)

## Interventions

- **DRUG:** NE3107
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06757010
- **Lead sponsor:** BioVie Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-26
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06757010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06757010, "A Study of NE3107 in Early Parkinson's". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06757010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*